Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?

To: brogan who wrote (19182)	3/11/2000 5:33:00 PM
From: Sergio H	Read Replies (1) \| Respond to of 29382

Eric, on target for IAIC lets just let parity do the job. Looking at long term chart, 30 comes into mind. Let's settle for somewhere in between 6 and 10 for short term and 20s if interest is there for a long term play. DRAX coverage by Gruntal is interesting. Gruntal was hired by DRAX to boost stock price back in Nov. That could be why the short term target of $7 didn't turn many heads, but it would lead one to expect DRAX is expecting FDA approval, probably for Brachytherapy. There's plenty more in the pipeline as well as excellent market penetration for established sales. Chartwise, DRAX has resistance at 4 5/8 then 5, then 6, then 9..... and so on. Did I mention the nice double bottom? Sergio